2007
DOI: 10.1016/j.bbrc.2006.11.012
|View full text |Cite
|
Sign up to set email alerts
|

Functional characterization of a mammalian transcription factor, Elongin A

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 28 publications
0
16
0
Order By: Relevance
“…Our reporter assays using various Elongin A mutants demonstrated that the C-terminal elongation activation domain including the BC box is crucial for the response of ATF3 gene, consistent with the activity in vitro (22,25,63). In addition, the N-terminal SII similarity region has a mild but positive regulatory role for the Elongin A-driven transcription activity in vivo (Fig.…”
Section: Discussionmentioning
confidence: 68%
See 3 more Smart Citations
“…Our reporter assays using various Elongin A mutants demonstrated that the C-terminal elongation activation domain including the BC box is crucial for the response of ATF3 gene, consistent with the activity in vitro (22,25,63). In addition, the N-terminal SII similarity region has a mild but positive regulatory role for the Elongin A-driven transcription activity in vivo (Fig.…”
Section: Discussionmentioning
confidence: 68%
“…Mammalian expression plasmids for rat Elongin A deletion mutants were as described (22). Rabbit polyclonal anti-RNAPII (N-20), anti-TFIIE-␣ (C-17), and anti-FCP1 (C-16) antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Elongin A, also known as transcription elongation factor S-III, increases the rate of transcription by suppressing transient pausing in the elongation complex (Yasukawa et al, 2007). CRSP70 is a subunit of the CRSP (cofactor required for Sp1 activation) complex which is required for the activity of the enhancer binding protein Sp1 Deniaud et al, 2006).…”
Section: Introductionmentioning
confidence: 99%